BRIEF—Hikma and Perrigo agree distribution deal in MENA region

London-listed Hikma Pharmaceuticals has signed a licensing and distribution agreement with an affiliate of OTC healthcare firm Perrigo Company.

The deal gives Hikma the exclusive right to license and distribute more than 30 consumer healthcare products in the Middle East and North Africa (MENA) region, with the exception of current agreements in place.

Hikma says it will “work with Perrigo’s existing partners in the MENA region to broaden sales and marketing coverage.” The firm also has the right of first refusal to the full range of Perrigo’s OTC medicines in the region.

Hikma has sales and marketing operations in 17 markets in the area, with expertise in the consumer health business.